EXTRA2

Mouse ExtrAvidin^® Peroxidase Staining Kit antibody produced in goat

Name: Mouse ExtrAvidin<SUP>®</SUP> Peroxidase Staining Kit antibody produced in goat
Brand: SIGMA
Price: 2900 PLN

Synonim(y):

ExtrAvidin^® Peroxidase Staining Kits

Slide 1 of 1

Zaloguj się, aby wyświetlić ceny organizacyjne i kontraktowe.

Wybierz wielkość

1 KIT

2900,00 zł

Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności

Zamów zamówienie zbiorcze

Informacje o tej pozycji

NACRES:

NA.32

UNSPSC Code:

12352203

Kluczowe dokumenty

Wyświetl całą dokumentację

Przejdź do

Pomoc techniczna

Potrzebujesz pomocy? Nasz zespół doświadczonych naukowców chętnie Ci pomoże.

Pozwól nam pomóc

antibody product type

secondary antibodies

usage

sufficient for 2,000 tests ELISA, Immunoblotting, sufficient for 200 tests Immunohistology

shipped in

wet ice

storage temp.

2-8°C

target post-translational modification

unmodified

Quality Level

200

Powiązane kategorie

Protein Biology

Secondary Antibodies

Antibodies - Primary, Secondary & Recombinant Monoclonal

Porównaj podobne pozycje

Wyświetl pełne porównanie

Pokaż różnice

1 of 4

Ta pozycja	SAB3700434	SAB3701073	SAB3700420
Sigma-Aldrich EXTRA2 Mouse ExtrAvidin^® Peroxidase Staining Kit antibody produced in goat	Sigma-Aldrich SAB3700434 Anti-Swine IgG (H+L)-Peroxidase antibody produced in goat	Sigma-Aldrich SAB3701073 Anti-Mouse IgG (H+L), highly cross adsorbed-Peroxidase antibody produced in goat	Sigma-Aldrich SAB3700420 Anti-Swine IgG F(ab′)₂-Peroxidase antibody produced in rabbit
shipped in wet ice	shipped in wet ice	shipped in wet ice	shipped in wet ice
storage temp. 2-8°C	storage temp. 2-8°C	storage temp. 2-8°C	storage temp. 2-8°C
antibody product type secondary antibodies	antibody product type secondary antibodies	antibody product type secondary antibodies	antibody product type secondary antibodies
usage sufficient for 2,000 tests ELISA, Immunoblotting	usage -	usage -	usage -
target post-translational modification unmodified	target post-translational modification unmodified	target post-translational modification unmodified	target post-translational modification unmodified
Quality Level 200	Quality Level 100	Quality Level 100	Quality Level 100

General description

Contain universal reagents for use with primary antibodies in immunohistology, ELISA, and immunoblotting.
ExtrAvidin^® is a unique form of avidin, available only from Sigma, that combines the high specificity and affinity of avidin for biotin with low non-specific binding at physiological pH.

These kits comprise universal reagents for use with primary antibodies in immunohistology, ELISA, and immunoblotting.
ExtrAvidin^® is a unique form of avidin, available only from Sigma, that combines the high specificity and affinity of avidin for biotin with low non-specific binding at physiological pH. ExtrAvidin^® peroxidase exhibits high sensitivity with low background.

Application

Applications in which this antibody has been used successfully, and the associated peer-reviewed papers, are given below.
Immunohistochemistry (1 paper)

Features and Benefits

Use in immunohistology, ELISA, and immunoblotting assays.
Affinity Isolated Antibodies have been adsorbed with human IgG and IgM to minimize cross-reactivity.
Biotinylated antibodies contain a spacer which improves accessibility for the ExtrAvidin^® conjugates.

Other Notes

• 3 mL ExtrAvidin^®-Peroxidase
• 3 mL Biotinylated Secondary Antibodies
• Complete Instructions and Assay Protocols

Legal Information

ExtrAvidin is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

For U.S. Customers: Contains mercury; Do not place in trash - dispose according to local, state, or federal laws.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Nie możesz znaleźć właściwego produktu?

Wypróbuj nasz Narzędzie selektora produktów.

Klasa składowania

12 - Non Combustible Liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)

pictograms

GHS08

signalword

Danger

hcodes

H334

pcodes

P261 - P284 - P501

Hazard Classifications

Resp. Sens. 1

Wykazy regulacyjne

Wykazy regulacyjne dotyczą głównie produktów chemicznych. Można w nich podawać ograniczoną liczbę informacji na temat produktów niechemicznych. Brak wpisu oznacza, że żaden ze składników nie znajduje się w wykazie. Użytkownik odpowiada za zagwarantowanie bezpiecznego i zgodnego z prawem stosowania produktu.

54-64-8

CAS No.

rmu

Wybierz jedną z najnowszych wersji:

Certyfikaty analizy (CoA)

Lot/Batch Number

0000377873

0000245216

0000173984

Nie widzisz odpowiedniej wersji?

Jeśli potrzebujesz konkretnej wersji, możesz wyszukać konkretny certyfikat według numeru partii lub serii.

Wyszukaj dokument COA

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów

Methylglyoxal Exacerbates Lipopolysaccharide-Induced Acute Lung Injury via RAGE-Induced ROS Generation: Protective Effects of Metformin.

Matheus L Medeiros et al.

Journal of inflammation research, 14, 6477-6489 (2021-12-10)

Methylglyoxal (MGO) is a highly reactive dicarbonyl species implicated in diabetic-associated diseases. Acute lung injury (ALI) symptoms and prognosis are worsened by diabetes and obesity. Here, we hypothesized that elevated MGO levels aggravate ALI, which can be prevented by metformin.

Enhanced RAGE Expression and Excess Reactive-Oxygen Species Production Mediates Rho Kinase-Dependent Detrusor Overactivity After Methylglyoxal Exposure.

Akila L Oliveira et al.

Frontiers in physiology, 13, 860342-860342 (2022-04-15)

Methylglyoxal (MGO) is a highly reactive dicarbonyl compound implicated in diabetes-associated diseases. In vascular tissues, MGO induces the formation of advanced glycation end products (AGEs) that bounds its receptor RAGE, initiating the downstream tissue injury. Outside the cardiovascular system, MGO

Neuroprotective action of diazepam at very low and moderate doses in Alzheimer's disease model rats.

Vladimirs Pilipenko et al.

Neuropharmacology, 144, 319-326 (2018-11-09)

Early manifestations of Alzheimer's disease (AD) include neuroinflammation, disrupted neurotransmission and cognitive deficits. Impairment of the GABAergic system is essentially involved in the pathogenesis of AD. Traditionally, agonists of GABAA receptors at doses above 1 mg/kg are known to possess memory

Powiązane treści

Data Sheet - EXTRA2

Instructions

Questions

Reviews

No rating value

Active Filters

Nasz zespół naukowców ma doświadczenie we wszystkich obszarach badań, w tym w naukach przyrodniczych, materiałoznawstwie, syntezie chemicznej, chromatografii, analityce i wielu innych dziedzinach.

Skontaktuj się z zespołem ds. pomocy technicznej

Mouse ExtrAvidin® Peroxidase Staining Kit antibody produced in goat